Compare DECK & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DECK | CRL |
|---|---|---|
| Founded | 1973 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 13.1B |
| IPO Year | 1996 | 1999 |
| Metric | DECK | CRL |
|---|---|---|
| Price | $85.07 | $338.62 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 27 | 17 |
| Target Price | $96.74 | ★ $318.87 |
| AVG Volume (30 Days) | ★ 3.2M | 1.1M |
| Earning Date | 10-22-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.90 | N/A |
| EPS | ★ 3.24 | N/A |
| Revenue | ★ $5,472,296,000.00 | $1,857,601,000.00 |
| Revenue This Year | $4.33 | N/A |
| Revenue Next Year | $5.81 | $2.53 |
| P/E Ratio | $25.32 | ★ N/A |
| Revenue Growth | 9.76 | ★ 10.48 |
| 52 Week Low | $77.37 | $146.20 |
| 52 Week High | $122.29 | $379.63 |
| Indicator | DECK | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 55.16 | 56.93 |
| Support Level | $77.64 | $151.03 |
| Resistance Level | $88.40 | N/A |
| Average True Range (ATR) | 2.81 | 16.46 |
| MACD | -0.03 | 2.42 |
| Stochastic Oscillator | 64.79 | 53.02 |
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.